| | | | | |
DSGN Design Therapeutics, Inc. Common Stock | €12,9138 | -1,31% | €814,08M | €626,51K | |
PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares | €9,5629 | -3,22% | €813,73M | €10,22K | |
OXLC Oxford Lane Capital Corp. | €8,2999 | +0,52% | €813,63M | €487,39K | |
| €7,5438 | -0,90% | €811,47M | €558,83K | |
| €2,0277 | -1,67% | €810,85M | €968,31K | |
THFF First Financial Corporation Common Stock | €66,3990 | -0,77% | €810,65M | €140,41K | |
OLMA Olema Pharmaceuticals, Inc. Common Stock | €8,9056 | -5,64% | €808,16M | €495,83K | |
ABX Abacus Global Management, Inc. | €8,2655 | -1,13% | €807,46M | €255,81K | |
GOOS Canada Goose Holdings Inc. | €6,5557 | -1,55% | €807,10M | €744,81K | |
ACDC ProFrac Holding Corp. Class A Common Stock | €4,7170 | +1,29% | €805,87M | €632,12K | |
RPC Ridgepost Capital, Inc. | €6,9767 | -1,81% | €805,09M | €331,34K | |
PSIX Power Solutions International, Inc. Common Stock | €36,1165 | -2,60% | €802,42M | €316,78K | |
| €7,1743 | -6,49% | €802,33M | €3,79M | |
FRBT Forbright, Inc. Class A Common Stock | €15,9339 | -1,93% | €800,46M | €96,80K | |
| €16,3764 | -3,10% | €799,56M | €465,45K | |
